Loading...
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
OBJECTIVE: Inaccessibility of the inflammation compartmentalized to the central nervous system (CNS) may underlie the lack of efficacy of immunomodulatory treatments in progressive multiple sclerosis (MS). The double blind combination of Rituximab by IntraVenous and IntraThecAl injection versus plac...
Saved in:
| Published in: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774261/ https://ncbi.nlm.nih.gov/pubmed/27042677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.293 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|